Literature DB >> 19243518

Effect of body mass index on the outcome of infections: a systematic review.

M E Falagas1, A P Athanasoulia, G Peppas, D E Karageorgopoulos.   

Abstract

It has not been adequately evaluated whether the outcome of infections differs by body-weight category. We performed a systematic review of relevant studies. Eleven studies (one retrospective and 10 prospective cohort studies) were included in this review, involving a total of 3159 hospitalized patients or nursing home residents. Most studies (6/11) referred to lower respiratory tract infections. Seven studies showed an association of patient outcome (mortality in 6/7 studies) with body-weight category. This was shown in multivariate analysis in 4/5 studies that reported relevant data. Obese or morbidly obese patients with infections had worse outcome compared with the rest of the patients or with normal-weight patients, in 4/7 studies that reported relevant data; findings were not significant in the remaining three studies. Patients in the lowest body mass index (BMI) group had worse outcome compared with all other groups combined, in 3/5 studies that reported relevant data; findings were not significant in the remaining two studies. Low BMI was associated with worse outcome in patients with lower respiratory tract infections in 3/4 relevant studies. Although not consistently reported, an association of both ends of the BMI distribution with worse outcome of infections is plausible and merits further investigation.

Entities:  

Mesh:

Year:  2008        PMID: 19243518     DOI: 10.1111/j.1467-789X.2008.00546.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  42 in total

1.  The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning.

Authors:  Gülsan Türköz Sucak; Elif Suyanı; Nuran Ahu Baysal; Şermin Altındal; Merih Kizil Çakar; Şahika Zeynep Akı; Zeynep Arzu Yeğin; Nevin Şanlıer
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

2.  Impaired wound healing predisposes obese mice to severe influenza virus infection.

Authors:  Kevin B O'Brien; Peter Vogel; Susu Duan; Elena A Govorkova; Richard J Webby; Jonathan A McCullers; Stacey Schultz-Cherry
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

3.  Obesity Is Associated with Decreased Risk of Clostridium difficile Infection in Hospitalized Patients with Pouchitis.

Authors:  Falgun Gosai; Fahrettin Covut; Mohammad Alomari; Asif Hitawala; Amandeep Singh; Gaurav Kisangani; Rocio Lopez; Bo Shen
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

Review 4.  Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere.

Authors:  M E Falagas; N V Cholevas; A M Kapaskelis; E K Vouloumanou; A Michalopoulos; P I Rafailidis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-13       Impact factor: 3.267

5.  Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjects.

Authors:  Julie Ann Justo; Stockton M Mayer; Manjunath P Pai; Melinda M Soriano; Larry H Danziger; Richard M Novak; Keith A Rodvold
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

6.  The dangers of extreme body mass index values in patients with Clostridium difficile.

Authors:  Brian H Nathanson; Thomas L Higgins; William T McGee
Journal:  Infection       Date:  2017-06-07       Impact factor: 3.553

Review 7.  Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology.

Authors:  Jennifer H Martin; Mohamed Saleem; David Looke
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

8.  Information provision for antibacterial dosing in the obese patient: a sizeable absence?

Authors:  Sara Elizabeth Boyd; Esmita Charani; Tracy Lyons; Gary Frost; Alison Helen Holmes
Journal:  J Antimicrob Chemother       Date:  2016-08-18       Impact factor: 5.790

9.  The effect of obesity on clinical outcomes in presumed sepsis: a retrospective cohort study.

Authors:  Timothy Glen Gaulton; Mark Gordon Weiner; Knashawn Hodge Morales; David Foster Gaieski; Jimish Mehta; Ebbing Lautenbach
Journal:  Intern Emerg Med       Date:  2013-09-27       Impact factor: 3.397

10.  Obesity and outcomes in patients hospitalized with pneumonia.

Authors:  S Kahlon; D T Eurich; R S Padwal; A Malhotra; J K Minhas-Sandhu; T J Marrie; S R Majumdar
Journal:  Clin Microbiol Infect       Date:  2012-09-11       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.